Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Su Zhao

Showing results (191-200 of 233) with videos related to

Pageof 24
Sort By:
British Journal of Haematology|May 4, 2017
Recipient-donor KIR ligand matching prevents CMV reactivation post-haploidentical T cell-replete transplantationXiang-Yu Zhao, Xue-Yi Luo, Xing-Xing Yu, et al.
Cell Death and Differentiation|January 28, 2026
Parvovirus B19 targets hematopoietic stem cells to disrupt multilineage differentiation and drive pancytopeniaXu-Ying Pei, Zhuo-Jun Liu, Qiang Fu, et al.
American Journal of Hematology|September 21, 2017
Effects of pre- and post-transplantation minimal residual disease on outcomes in pediatric patients with acute myeloid leukemia receiving human leukocyte antigen-matched or mismatched related donor allograftsYing-Jun Chang, Xiao-Su Zhao, Yu Wang, et al.
Plos Pathogens|February 17, 2022
Total infectome characterization of respiratory infections in pre-COVID-19 Wuhan, ChinaMang Shi, Su Zhao, Bin Yu, et al.
Leukemia & Lymphoma|July 1, 2021
Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemiaHao Jiang, Xiao-Hong Liu, Jun Kong, et al.
Signal Transduction and Targeted Therapy|May 4, 2025
Overexpressing natural killer group 2 member A drives natural killer cell exhaustion in relapsed acute myeloid leukemiaJuan Xie, Xue-Fei Liu, Tong Zhou, et al.
British Journal of Haematology|April 27, 2024
A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapyFei-Fei Tang, Wen-Bing Duan, Xiao-Hong Liu, et al.
Oncoimmunology|February 10, 2017
Lower incidence of acute GVHD is associated with the rapid recovery of CD4<sup>+</sup>CD25<sup>+</sup>CD45RA<sup>+</sup> regulatory T cells in patients who received haploidentical allografts from NIMA-mismatched donors: A retrospective (development) and prospective (validation) cohort-based studyYu Wang, Xiang-Yu Zhao, Lan-Ping Xu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|March 7, 2014
[A new multi-factor risk score system for predicting the outcome after allogenic hematopoietic stem cell transplantation]Jing Liu, Lan-Ping Xu, Dai-Hong Liu, et al.
Haematologica|October 12, 2023
Targeting T<sub>FH</sub> cells is a novel approach for donor-specific antibody desensitization of allograft candidates: an <i>in vitro</i> and <i>in vivo</i> studyNing Ma, Wei-Bing Wu, Xiang-Yu Zhao, et al.
Pageof 24

Showing results (191-200 of 233) with videos related to

Sort By:
Pageof 24
British Journal of Haematology|May 4, 2017
Recipient-donor KIR ligand matching prevents CMV reactivation post-haploidentical T cell-replete transplantationXiang-Yu Zhao, Xue-Yi Luo, Xing-Xing Yu, et al.
Cell Death and Differentiation|January 28, 2026
Parvovirus B19 targets hematopoietic stem cells to disrupt multilineage differentiation and drive pancytopeniaXu-Ying Pei, Zhuo-Jun Liu, Qiang Fu, et al.
American Journal of Hematology|September 21, 2017
Effects of pre- and post-transplantation minimal residual disease on outcomes in pediatric patients with acute myeloid leukemia receiving human leukocyte antigen-matched or mismatched related donor allograftsYing-Jun Chang, Xiao-Su Zhao, Yu Wang, et al.
Plos Pathogens|February 17, 2022
Total infectome characterization of respiratory infections in pre-COVID-19 Wuhan, ChinaMang Shi, Su Zhao, Bin Yu, et al.
Leukemia & Lymphoma|July 1, 2021
Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemiaHao Jiang, Xiao-Hong Liu, Jun Kong, et al.
Signal Transduction and Targeted Therapy|May 4, 2025
Overexpressing natural killer group 2 member A drives natural killer cell exhaustion in relapsed acute myeloid leukemiaJuan Xie, Xue-Fei Liu, Tong Zhou, et al.
British Journal of Haematology|April 27, 2024
A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapyFei-Fei Tang, Wen-Bing Duan, Xiao-Hong Liu, et al.
Oncoimmunology|February 10, 2017
Lower incidence of acute GVHD is associated with the rapid recovery of CD4<sup>+</sup>CD25<sup>+</sup>CD45RA<sup>+</sup> regulatory T cells in patients who received haploidentical allografts from NIMA-mismatched donors: A retrospective (development) and prospective (validation) cohort-based studyYu Wang, Xiang-Yu Zhao, Lan-Ping Xu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|March 7, 2014
[A new multi-factor risk score system for predicting the outcome after allogenic hematopoietic stem cell transplantation]Jing Liu, Lan-Ping Xu, Dai-Hong Liu, et al.
Haematologica|October 12, 2023
Targeting T<sub>FH</sub> cells is a novel approach for donor-specific antibody desensitization of allograft candidates: an <i>in vitro</i> and <i>in vivo</i> studyNing Ma, Wei-Bing Wu, Xiang-Yu Zhao, et al.
Pageof 24